Business Segments Eli Lilly and Company

Equities

Market Closed - Nyse Other stock markets 04:00:02 2024-09-16 pm EDT			5-day change	1st Jan Change
923.54 ^USD	-0.02%		+1.68%	+58.43%

Sep. 16	Swiss Market Index Closes in Red; Roche Slips	MT
Sep. 16	Central bank bonanza!

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment

Fiscal Period: December	2019	2020	2021	2022	2023
Pharmaceutical Products
Discovery, Dev., Manufacturing, Marketing, and Sales of Pharmaceutical Products	22.32B	24.54B	28.32B	28.54B	34.12B
Total Assets	39.29B	46.63B	48.81B	49.49B	64.01B
Interest Expense	-401M	-360M	-340M	-332M	-486M
Income Tax Expense	628M	1.04B	574M	562M	1.31B
CAPEX	-1.35B	-2.03B	-1.87B	-2.48B	-3.45B
EBT	5.27B	7.23B	6.16B	6.81B	6.55B
D&A	1.23B	1.32B	1.55B	1.52B	1.53B
Net Income	8.32B	6.19B	5.58B	6.24B	5.24B
EBT	-	-	-	-	-
EBT	-	-	-	-	-
EBT	-	-	-	-	-
EBT	-	-	-	-	-
EBT	-	-	-	-	-
EBT	-	-	-	-	-
EBT	-	-	-	-	-
Veterinary Drugs
Animal Health Products	-	-	-	-	-
EBT	-	-	-	-	-
D&A	-	-	-	-	-

Geographical breakdown of sales

Fiscal Period: December	2019	2020	2021	2022	2023
United States (U.S.)	12.72B	14.23B	16.81B	18.19B	21.79B
Total Assets	-	-	-	-	-
Europe	3.76B	4.19B	4.78B	4.3B	6.17B
Total Assets	-	-	-	-	-
Other Foreign Countries	3.28B	2.42B	2.7B	2.85B	2.95B
Total Assets	1.76B	1.75B	1.69B	1.63B	1.78B
Japan	2.55B	2.58B	2.37B	1.75B	1.67B
Total Assets	-	-	-	-	-
Total Assets	5.6B	6.11B	6.62B	7.71B	9.99B
Total Assets	1.45B	1.79B	1.7B	1.9B	2.72B
China	-	1.12B	1.66B	1.45B	1.54B